Emmaus Life Sciences, Inc. today reported on its financial condition and results of operations as of and for the three months ended March 31, 2023.
Read More
Emmaus announced today preliminary results for the 3 months that ended March 31, 2023.
Read More
Emmaus Life Sciences, Inc. (OTCQX: EMMA), today reported its results of operation for the year ended December 31, 2022 and an update on recent activities.
Read More
Cites Large, Unserved Needs of Sickle Cell Disease Patient
Read More
Emmaus Life Sciences, Inc. announced today that Dr. Yutaka Niihara, Chairman and Chief Executive Officer of the company, was feted at an event held on December 16, 2022 at the World Trade Center in Mumbai, India by the Minister of State of India, Arun Halder, in recognition of Dr. Niihara’s work in developing Endari to treat sickle cell disease (SCD).
Read More